Skip to main content
. 2016 Aug 3;4(3):e94. doi: 10.2196/mhealth.6002

Table 3.

Experimental participant program (n=25) acceptability ratings based on a 5-point Likert scale (1 for “not at all” and 5 for “extremely”) at 3-month follow-up.



mean (SD)
How helpful was . . .

Your varenicline (Chantix) prescription? 4.4 (1.1)

Feedback you received from the MyMAP staff? 4.1 (1.4)

Advice you received for how to manage your nicotine withdrawal symptoms and medication side-effects? 3.8 (1.3)

MyMAP Quit Guide and materials? 3.7 (1.3)

Motivational encouragement you received to help you quit smoking or stay quit? 3.1 (1.5)
How satisfied were you with . . .

Confidentiality of the MyMAP program? 4.6 (1.0)

Ease of using the MyMAP program? 4.6 (0.7)

Convenience of the MyMAP program? 4.5 (0.9)

Information and support you received about taking varenicline (Chantix)? 4.4 (1.1)

Responsiveness of the MyMAP team to your needs? 4.4 (1.2)

Reminders you received to log in to the MyMAP program? 4.3 (1.2)

Content of the MyMAP program ? 3.8 (1.1)

Personalized advice you received for managing your symptoms and side-effects? 3.6 (1.4)